Ultime notizie per Elis (OTC:ELSSF) Azioni

Elis SA provides multiservice solutions to various end markets including the hospitality, healthcare, and commerce industries. The company's products and services include providing flat linen, workwear, hygiene products, and well-being services. The company operates in various countries across Europe and Latin America, with a majority of revenue stemming from France.

Elis SA

Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHC#NASDAQ">SHC</a>) with a Overweight and lowers the price target from $16 to $12.

News

Price Target

Analyst Ratings

Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $12

<a href="https://www.federalreserve.gov/newsevents/testimony/bowman20250410a.htm">https://www.federalreserve.gov/newsevents/testimony/bowman20250410a.htm</a>

Macro Economic Events

Politics

Economics

Federal Reserve

General

Fed's Bowman Asked If Will Stand Up For Fed Independence, Says 'Absolutely'; Says Agree With Principles Of Cost-benefit Analysis To Support Rule-Makings

Trading Ideas

ATHR

Aether Holdings Shares Halted On Circuit Breaker To The Upside

IPOs

Aether Holdings IPO Shares Open For Trade At $5.25/Share

Barclays analyst Luke Sergott maintains Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) with a Overweight and lowers the price target from $140 to $110.

RVTY

Barclays Maintains Overweight on Revvity, Lowers Price Target to $110

ChargePoint Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) on Thursday unveiled a major upgrade in <a href="https://www.benzinga.com/pressreleases/25/04/b44729894/chargepoint-innovations-transform-ev-charging-with-maximum-speed-bidirectional-ac-architecture" target="_blank" rel="noreferrer noopener">AC Level 2 charging technology</a>.
The next-gen architecture introduces bidirectional charging and delivers charging speeds up to twice as fast as current AC Level 2 chargers.
ChargePoint&#8217;s new AC Level 2 architecture offers faster charging of up to 19.2 KW in North America and 22 KW in Europe, vehicle-to-everything capability, and dynamic load balancing.
The platform will support commercial, residential, and fleet use cases across North America and Europe.
It will meet key regulatory standards, including MID and Eichrecht in Europe and ENERGY STAR in the U.S. Initial models will launch in Europe this summer, followed by North America at the end of 2025.
It supports smart home integration, series wiring for multiple EVs without costly upgrades, and universal compatibility via the ChargePoint Omni Port.
The new AC Level 2 charging architecture builds on ChargePoint's nearly 20 years of leadership in EV charging, during which it has captured an estimated 61% share of the U.S. public AC Level 2 market, according to Alternative Fuels Data Center data.
Hossein Kazemi, chief technical officer of hardware at ChargePoint said, &#8220;The architecture underpinning them enables highly anticipated technologies which will deliver a significantly better experience for station owners and the EV drivers who charge with them.&#8221;
Last month, ChargePoint introduced five ultra-fast charging stations in upstate New York, located in Cortland,<a href="https://www.benzinga.com/25/03/44306956/whats-going-on-with-ev-charging-provider-chargepoints-stock-today" target="_blank" rel="noreferrer noopener"> Waterloo, Lake Placid, Niagara Falls, and Ripley</a>.
Investors can gain exposure to the stock via&nbsp;WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/WBAT#BATS">WBAT</a>).
Price Action: CHPT shares are down 2.53% at $0.5814 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44721134/cf-industries-jera-mitsui-form-4b-jv-to-build-low-carbon-ammonia-plant-in-louisiana" target="_blank" rel="noreferrer noopener">CF Industries, JERA, Mitsui Form $4 Billion JV To Build Low-Carbon Ammonia Plant In Louisiana</a></li>
</ul>
Photo: Shutterstock/YuniqueB

Equities

Small Cap

Movers

CHPT

WBAT

What's Going On With ChargePoint Shares Premarket On Thursday?

Barclays analyst Luke Sergott maintains Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) with a Overweight and lowers the price target from $200 to $160.

NTRA

Barclays Maintains Overweight on Natera, Lowers Price Target to $160

Barclays analyst Jack Meehan maintains Labcorp Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) with a Equal-Weight and lowers the price target from $260 to $240.

Laboratory Corporation Of America Holdings

Barclays Maintains Equal-Weight on Labcorp Hldgs, Lowers Price Target to $240

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) with a Underweight and lowers the price target from $100 to $77.

ILMN

Barclays Maintains Underweight on Illumina, Lowers Price Target to $77

HC Wainwright &amp; Co. analyst Edward White reiterates Inozyme Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) with a Buy and maintains $16 price target.

Reiteration

INZY

HC Wainwright & Co. Reiterates Buy on Inozyme Pharma, Maintains $16 Price Target

Barclays analyst Luke Sergott maintains Guardant Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) with a Overweight and lowers the price target from $60 to $55.

Barclays Maintains Overweight on Guardant Health, Lowers Price Target to $55

Hong Kong, April 10, 2025 (GLOBE NEWSWIRE) -- MasterBeef Group (the &quot;Company&quot;), a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue, today announced the pricing of its initial public offering (the &quot;Offering&quot;) of 2,000,000 ordinary shares, par value US$0.0005 per share, at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on April 10, 2025 under the ticker symbol &quot;MB&quot;. The Company is also registering an aggregate of 1,815,000 ordinary shares for the potential resale by certain shareholders of the Company. These shares will not be underwritten by the underwriters and the Company will not receive any proceeds from the sale of the shares held by these resale shareholders.
The Company expects to receive aggregate gross proceeds of US$8.0 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about April 11, 2025, subject to the satisfaction of customary closing conditions.

MasterBeef Group Prices IPO Of 2M Shares At A Price Of $4/Share

Fed's Bowman Says Stress Test Process Will Move Forward As Planned

<a href="https://www.cnbc.com/2025/04/10/china-trump-tariffs-live-updates.html">https://www.cnbc.com/2025/04/10/china-trump-tariffs-live-updates.html</a>
&nbsp;
<h2>U.S. tariffs on China now total 145% after latest hike, White House says</h2>
The U.S. tariff rate on Chinese imports now effectively totals 145%, a White House official confirmed to CNBC.
Trump's latest executive order hikes tariffs on Beijing to 125% from 84%.
But that comes on top of a 20% fentanyl-related tariff that Trump previously imposed on China.

Global

"Trump Tariffs On China Now Total 145%, White House Clarifies" - CNBC

<a href="https://www.federalreserve.gov/newsevents/testimony/bowman20250410a.htm" title="https://www.federalreserve.gov/newsevents/testimony/bowman20250410a.htm">https://www.federalreserve.gov/newsevents/testimony/bowman20250410a.htm</a>

Fed's Bowman Says Economy Is Strong; Growth Solid, But Slowing; Inflation Came Down, CPI Report Shows; Watching To See How Evolving Policies Affect Economy; Unclear How Tariffs Affect Economy; Tariff Effect On Industry Unclear; Has Been Volatility In Stock Market

<a href="https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/">https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/</a>&nbsp;

Fed's Schmid Says Not Sure If There Is A Currency That Could Compete With The Dollar

Investors with a lot of money to spend have taken a bullish stance on NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NIO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 16 uncommon options trades for NIO.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $357,865, and 9 are calls, for a total amount of $469,428.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $2.0 to $12.0 for NIO over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for NIO's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across NIO's significant trades, within a strike price range of $2.0 to $12.0, over the past month.
<h3>NIO Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744297294_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$0.97</td>
<td>$0.94</td>
<td>$0.97</td>
<td>$3.00</td>
<td>$97.1K</td>
<td>23.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$0.64</td>
<td>$0.61</td>
<td>$0.61</td>
<td>$5.00</td>
<td>$61.4K</td>
<td>6.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$0.64</td>
<td>$0.61</td>
<td>$0.61</td>
<td>$5.00</td>
<td>$60.9K</td>
<td>6.1K</td>
<td>5.0K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$0.64</td>
<td>$0.61</td>
<td>$0.61</td>
<td>$5.00</td>
<td>$60.9K</td>
<td>6.1K</td>
<td>3.0K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$0.64</td>
<td>$0.61</td>
<td>$0.61</td>
<td>$5.00</td>
<td>$60.9K</td>
<td>6.1K</td>
<td>2.0K</td>
</tr>
</tbody>
</table>

<h3>About NIO</h3>
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.
Following our analysis of the options activities associated with NIO, we pivot to a closer look at the company's own performance.
<h3>Current Position of NIO</h3>
<ul>
<li>Trading volume stands at 15,198,731, with NIO's price down by -0.6%, positioned at $3.29.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 56 days.</li>
</ul>
<h3>Professional Analyst Ratings for NIO</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $5.27.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on NIO, which currently sits at a price target of $8. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on NIO with a target price of $4. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Neutral rating for NIO, targeting a price of $3. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for NIO with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

Looking At NIO's Recent Unusual Options Activity

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LLY usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 41 extraordinary options activities for Eli Lilly. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 29% leaning bullish and 60% bearish. Among these notable options, 22 are puts, totaling $2,089,300, and 19 are calls, amounting to $830,558.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $500.0 to $1220.0 for Eli Lilly during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Eli Lilly stands at 313.46, with a total volume reaching 493.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly, situated within the strike price corridor from $500.0 to $1220.0, throughout the last 30 days.
<h3>Eli Lilly Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744297289_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$91.4</td>
<td>$87.9</td>
<td>$90.6</td>
<td>$790.00</td>
<td>$724.8K</td>
<td>342</td>
<td align="right">80</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$81.3</td>
<td>$79.25</td>
<td>$81.3</td>
<td>$700.00</td>
<td>$162.6K</td>
<td>1.1K</td>
<td align="right">0</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$91.25</td>
<td>$88.7</td>
<td>$91.25</td>
<td>$720.00</td>
<td>$146.0K</td>
<td>346</td>
<td align="right">19</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$86.55</td>
<td>$85.3</td>
<td>$86.55</td>
<td>$710.00</td>
<td>$138.4K</td>
<td>194</td>
<td align="right">16</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$105.9</td>
<td>$104.85</td>
<td>$105.9</td>
<td>$730.00</td>
<td>$105.9K</td>
<td>100</td>
<td align="right">12</td>
</tr>
</tbody>
</table>

<h3>About Eli Lilly</h3>
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Eli Lilly's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 624,788, the LLY's price is down by -3.76%, now at $725.34. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 21 days.</li>
</ul>
<h3>Expert Opinions on Eli Lilly</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $1006.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Showing optimism, an analyst from Goldman Sachs upgrades its rating to Buy with a revised price target of $888. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Eli Lilly, maintaining a target price of $1124. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Behind the Scenes of Eli Lilly's Latest Options Trends

A notable insider purchase on April 9, was reported by Ilham Kadri, Director at A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), based on the most recent SEC filing.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000091142/000009114225000059//Archives/edgar/data/91142/000009114225000059/0000091142-25-000059-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Kadri increased their investment in A.O. Smith by purchasing 2,468 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $150,005.
A.O. Smith shares are trading up 0.05% at $62.59 at the time of this writing on Thursday morning.
<h3>About A.O. Smith</h3>
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.
<h3>Understanding the Numbers: A.O. Smith's Finances</h3>
Revenue Growth: A.O. Smith's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -7.66%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 37.06%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): A.O. Smith's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.752617.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.12, A.O. Smith adopts a prudent financial strategy, indicating a balanced approach to debt management.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 17.23, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 2.41, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 11.34, A.O. Smith presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Important Transaction Codes</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000091142">Check Out The Full List Of A.O. Smith's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Smart Money Move: Ilham Kadri Grabs $150K Worth Of A.O. Smith Stock

Investors with a lot of money to spend have taken a bearish stance on Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PANW, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 21 uncommon options trades for Palo Alto Networks.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 57%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $364,473, and 14 are calls, for a total amount of $754,916.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $190.0 for Palo Alto Networks over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Palo Alto Networks stands at 803.0, with a total volume reaching 612.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Palo Alto Networks, situated within the strike price corridor from $115.0 to $190.0, throughout the last 30 days.
<h3>Palo Alto Networks Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744297284_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$30.8</td>
<td>$30.6</td>
<td>$30.6</td>
<td>$185.00</td>
<td>$134.6K</td>
<td align="right">579</td>
<td align="right">44</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$19.5</td>
<td>$19.4</td>
<td>$19.4</td>
<td>$155.00</td>
<td>$96.9K</td>
<td align="right">432</td>
<td align="right">52</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$19.95</td>
<td>$18.4</td>
<td>$19.1</td>
<td>$155.00</td>
<td>$95.5K</td>
<td align="right">432</td>
<td align="right">102</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$27.65</td>
<td>$24.95</td>
<td>$27.65</td>
<td>$150.00</td>
<td>$85.7K</td>
<td align="right">614</td>
<td align="right">44</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$6.35</td>
<td>$5.4</td>
<td>$6.35</td>
<td>$167.50</td>
<td>$83.1K</td>
<td align="right">228</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Palo Alto Networks</h3>
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
After a thorough review of the options trading surrounding Palo Alto Networks, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Palo Alto Networks</h3>
<ul>
<li>With a volume of 1,073,104, the price of PANW is down -2.36% at $168.94. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 39 days.</li>
</ul>
<h3>What The Experts Say On Palo Alto Networks</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $203.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Showing optimism, an analyst from HSBC upgrades its rating to Hold with a revised price target of $156. 
&#x2A; In a cautious move, an analyst from Stephens &amp; Co. downgraded its rating to Equal-Weight, setting a price target of $205. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Palo Alto Networks with a target price of $205. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Palo Alto Networks, targeting a price of $215. 
&#x2A; Consistent in their evaluation, an analyst from Rosenblatt keeps a Buy rating on Palo Alto Networks with a target price of $235. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Palo Alto Networks with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Comments

Elis

Notizie

Ultime notizie per Elis (OTC:ELSSF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO